Table 1 of Adamus, Mol Vis 2012; 18:2323-2337.
Treatment | Dose | Starting treatment | P60* | P90* | Significance to untreated** |
---|---|---|---|---|---|
RTL220 | 200 | P21 | 0.329±0.012 | p<0.05, n=14 | |
RTL220 | 200 | P30 | 0.302±0.008 | p<0.05, n=14 | |
RTL220 | 100 | P21 | 0.349±0.007 | p<0.05, n=6 | |
RTL220 | 50 | P21 | 0.438±0.007 | p<0.001, n=10 | |
RTL220 | 20 | P21 | 0.468±0.03 | p<0.001, n=6 | |
RTL101 | 200 | P30 | 0.277±0.006 | n=8 | |
RTL101 | 100 | P21 | 0.272±0.032 | n=6 | |
Untreated controls | 0 | n/a | 0.33±0.04 | 0.27±0.06 | n/a |